How Does Relpax Work? Mechanism of Action Explained in Plain English

Relpax (eletriptan) doesn't just mask migraine pain — it targets the underlying biological events that cause migraine attacks. Understanding how it works can help you use it more effectively and make informed decisions about your treatment.

Here's the mechanism of action explained simply, without a pharmacology degree required.

What Happens in Your Brain During a Migraine

During a migraine attack, several things happen simultaneously in the brain:

Blood vessels widen (vasodilation): The blood vessels surrounding the brain dilate and become inflamed. This is associated with the throbbing pain of a migraine attack.

Trigeminal nerve activation: The trigeminal nerve — the main sensory nerve of the face and head — becomes activated. This nerve releases inflammatory peptides (including CGRP, calcitonin gene-related peptide) around the brain's blood vessels, intensifying pain and inflammation.

Pain signal amplification: Pain signals are transmitted through the trigeminal nerve pathway into the brainstem and brain, where they are processed and experienced as the debilitating migraine headache — along with nausea, light sensitivity, and sound sensitivity.

What Relpax Does: A Two-Part Attack

Eletriptan is a selective serotonin (5-HT) receptor agonist — specifically, it activates the 5-HT1B and 5-HT1D subtypes (and to a lesser degree, 5-HT1F). "Agonist" means it mimics the effect of serotonin at these receptors. Here's what that does:

Part 1: Constricts Dilated Blood Vessels (via 5-HT1B)

By activating 5-HT1B receptors on the walls of cranial blood vessels, eletriptan causes those vessels to constrict (narrow). This reverses the vasodilation that contributes to migraine pain. Think of it as releasing the pressure in an over-inflated balloon around your brain.

Part 2: Blocks Inflammatory Peptide Release (via 5-HT1D)

By activating 5-HT1D receptors on the endings of the trigeminal nerve, eletriptan inhibits the release of those inflammatory neuropeptides — including CGRP and substance P — that make the pain worse. Less CGRP means less inflammation around the blood vessels, less pain signal amplification, and less nausea and light sensitivity.

Why Eletriptan Is Different From Other Triptans

All triptans share this basic mechanism, but they differ in potency, how quickly they're absorbed, how long they last, and how well they cross the blood-brain barrier. Eletriptan has two key pharmacological advantages:

High potency: Eletriptan binds with unusually high affinity to 5-HT1B and 5-HT1D receptors, making it more effective at lower doses than some other triptans.

Good CNS penetration: Eletriptan crosses the blood-brain barrier more effectively than earlier triptans (like sumatriptan), meaning it can act on central nervous system pain pathways as well as peripheral blood vessels. This may explain its superior efficacy in head-to-head studies.

How This Differs From CGRP Inhibitors (Gepants)

Newer migraine drugs like ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) work differently. Instead of activating serotonin receptors, they directly block CGRP receptors — preventing CGRP from binding and triggering inflammation. Gepants don't cause vasoconstriction, which makes them safer for patients with heart disease, but they don't have the same blood vessel-narrowing effect as triptans like eletriptan.

Why Take It at the First Sign of Migraine?

Eletriptan works best when the migraine is in its early stage. Once the pain becomes severe, the central sensitization process (where the brain's pain pathways become "turned up") is harder to reverse. Taking eletriptan early — at the first sign of headache or even aura — gives it the best chance of stopping the attack before it fully develops.

For dosing details and uses, see what is Relpax and how is it used. To understand which drugs interact with eletriptan, see our guide on Relpax drug interactions.